Brief: Heron Therapeutics Announces FDA Approval Of The Prior For Zynrelef
Sept 25 (Reuters) - Heron Therapeutics Inc HRTX.O :
* HERON THERAPEUTICS ANNOUNCES FDA APPROVAL OF THE PRIOR
APPROVAL
SUPPLEMENT APPLICATION FOR ZYNRELEF® VIAL ACCESS NEEDLE ("VAN")
* HERON THERAPEUTICS INC - VAN EXPECTED TO LAUNCH IN Q4 2024
Source text for Eikon: ID:nPn9YYYna
Further company coverage: HRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heron Therapeutics
See all newsHeron Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook
Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
Heron Therapeutics' Q1 revenue falls as oncology sales drop